ITGR Integer Holdings Corporation
$126.00▼ -0.04%
Healthcare
Other
After hours
$126.00▲ +0.00%
Sep 11, 4:09 PM ET
Volume 449.9K
Avg Volume (10D) 803.3K
Key Metrics & Fundamentals
Market Cap
$4.28B
P/E Ratio
34.4
Div Yield
–%
52W Range
62.00 - 126.80
% vs 50 MA
10.92%
% vs 200 MA
36.98%
RSI-14
76.1
MACD Histogram
-0.8800
Beta (1Y vs SPY)
0.63
Free Cash Flow
$37.04M
Gross Rev
$464.11M
Gross Profit
$112.94M
EBITDA
$76.76M
COGS
$351.17M
Operating Exp
$68.33M
Operating Income
$44.61M
EBIT
$44.61M
Pretax Income
$23.29M
Net Income
$23.61M
EPS (Diluted)
0.69
Price & Volume History
Loading chart…
Recent News
3 Hyped Up Stocks We Think Twice About
StockStory · Sep 12, 2026 2:43 AM
How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?
Zacks · Sep 4, 2026 3:04 PM
1 Surging Stock to Own for Decades and 2 Facing Challenges
StockStory · Aug 31, 2026 12:54 PM
GMED or ITGR: Which Is the Better Value Stock Right Now?
Zacks · Aug 27, 2026 3:40 PM
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
StockStory · Aug 16, 2026 4:45 AM
GMED vs. ITGR: Which Stock Is the Better Value Option?
Zacks · Aug 11, 2026 3:40 PM
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
Zacks · Aug 10, 2026 5:27 PM
KKR (KKR) Following Integer Bid Talk Faces A Fresh Valuation Test
Simply Wall St. · Aug 6, 2026 10:12 AM
Market Chatter: Citigroup Leading Preparations for Debt Financing to Support KKR-Integer Deal
MT Newswires · Aug 5, 2026 8:15 AM
Integer Holdings (ITGR) Stock Sees Fair Value Lift After KKR Deal Reshapes Analyst Views
Simply Wall St. · Aug 5, 2026 4:28 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ITGR's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.